Highlights
NASDAQ: BMRN       Biomarin Pharmaceuticals
Last Price Today's Change   Day's Range   Trading Volume
74.39   -1.79 (2.35%)  74.355 - 77.30  1,520,700

Overview

 
Avg Volume (4 weeks):1,319,180
4 Weeks Range:73.80 - 80.51
4 Weeks Price Volatility (%):
8.79%
52 Weeks Range:68.25 - 131.945
52 Weeks Price Volatility (%):
9.64%
Average Price Target: 133.00
Price Target Upside/Downside: +58.61

Headlines



No recent Headlines for this stock.


Business Background

BioMarin Pharmaceutical Inc. is a biotechnology company. The Company develops and commercializes pharmaceuticals for various diseases and medical conditions. As of December 31, 2016, the Company's therapy portfolio consisted of five products, and multiple clinical and pre-clinical product candidates. Its commercial products include Aldurazyme (laronidase) for Mucopolysaccharidosis I (MPS I), Firdapse (amifampridine phosphate) for Lambert Eaton Myasthenic Syndrome (LEMS), Kuvan (sapropterin dihydrochloride) for phenylketonuria (PKU), Naglazyme (galsulfase) for Mucopolysaccharidosis VI (MPS VI) and Vimizim (elosulfase alpha) for Mucopolysaccharidosis IV Type A (MPS IV A). The Company is conducting clinical trials on various product candidates for the treatment of various diseases. Its clinical product candidates include Brineura, pegvaliase, vosoritide, BMN 270 and BMN 250.

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

1994  6612  492  172 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 MGEN 1.26+0.74 
 TTNP 0.167+0.039 
 GE 7.42+0.32 
 AAPL 111.20-5.40 
 SPY 326.66-11.56 
 SQQQ 24.65+2.59 
 UVXY 23.14+4.07 
 NIO 27.51-0.93 
 XLF 23.61-0.62 
 F 7.70-0.22